NovaBridge Biosciences: eps_basic
| Value | {"per": "shares", "amount": -0.08, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-09-30 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0b06ce9d-1262-457c-b855-48a7d56f07de
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-25-323791Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/eps-basic/2025-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0b06ce9d-1262-457c-b855-48a7d56f07de
History
- no predecessors — first report